Volume 13, Number 9—September 2007
Methicillin-Resistant Staphylococcus aureus in Pigs with Exudative Epidermitis
Despite a strict control program for methicillin-resistant Staphylococcus aureus (MRSA) in human medicine in the Netherlands, MRSA was cultured from exudative epidermitis lesions of 4 piglets on a breeding farm, 20 pigs on a supplier farm, and 2 workers on these farms. The MRSA strains were indistinguishable, suggesting direct transmission.
Worldwide, methicillin-resistant Staphylococcus aureus (MRSA) causes hospital- and community-acquired infections in humans. In the Netherlands, the proportion of clinical human isolates that are methicillin resistant is still very low (2%) (1). A 2005 study in France identified pig farming as a risk factor for increased nasal colonization with S. aureus (2). The strains found in farmers were not found in nonfarmers but often caused swine infections, which suggests transmission between pigs and farmers. During 2004–2005, MRSA was cultured from 3 Dutch patients who had had contact with pigs (3). Investigators also found 6 carriers of MRSA among a group of 26 pig farmers. In the Netherlands, contact with pigs is now recognized as a risk factor for MRSA carriage.
In June 2006, a Dutch farmer contacted the Pig Health Unit of the Veterinary Faculty of Utrecht University about an outbreak of exudative epidermitis among his swine. On his breeding farm (farm A), which had 200 sows (22.5 piglets/sow/year), a high preweaning mortality rate (20%) was caused by exudative epidermitis. Exudative epidermitis is a skin disease normally caused by S. hyicus and is usually an acute infection in suckling and weanling piglets. On farm A, a litter of 3-week-old piglets housed in a crate had clinical signs of exudative epidermitis. Other pigs on this farm had been unsuccessfully treated with ceftiofur, cefquinome, tylosin, and trimethoprim/sulfonamides.
A skin lesion sample from 1 piglet was sent to the Veterinary Microbiological Diagnostic Center of Utrecht University, where it was plated on sheep blood agar and MacConkey agar and incubated at 37°C for 24 h. No growth was seen on MacConkey agar, but large numbers of hemolytic white colonies were found on the sheep blood agar. These colonies were identified as S. aureus by colony morphology examination, Gram staining, catalase and coagulase testing, and API ID32 Staph (bioMérieux, Marcy-l’Etoile, France). No S. hyicus was found. Antimicrobial drug susceptibility was determined by using an agar diffusion method with IsoSensitest agar (CM471, Oxoid, Basingstoke, UK) and Neosensitab discs (Rosco, Taastrup, Denmark). The breakpoints used were those recommended by the Dutch Committee on Guidelines for Susceptibility Testing (4). The S. aureus was susceptible to enrofloxacin, trimethoprim/sulfamethoxazole, and fusidic acid and resistant to ampicillin, gentamicin, kanamycin, tetracycline, erythromycin, lincomycin, and tylosin. Because this S. aureus was resistant to multiple drugs, it was suspected of being MRSA, and presence of the mecA gene was confirmed by PCR (5).
Farm A was revisited 2 weeks later. Additional samples were taken from the skin lesions, nares, or both of 5 other 3-week-old piglets with exudative epidermitis from a different litter than the first piglet; from the nares of 1 healthy sow; and from the nares and throats of 2 veterinary students. The students had had contact with the pigs on the day the samples were taken and 1 week earlier. To investigate the source of the MRSA, samples were also taken from the nares of 12 healthy weanling pigs and 10 healthy gilts on a supplier farm (farm B) that had provided gilts for breeding to farm A. Nares samples were also taken from 2 farmers on farm B (Table). The samples were plated on sheep blood agar and incubated in tryptic soy broth, 4% saline, 1% mannitol, phenol red (16 μg/mL), ceftizoxime (5 μg/mL), and aztreonam (50 μg/mL). After incubation at 37°C for 48 h, broth cultures were plated on sheep blood agar and incubated at 37°C for 24 h. Suspected colonies were identified as MRSA, and antimicrobial drug susceptibility was determined as described above. MRSA was cultured from the nares of 1 student (farm A), 1 farmer (farm B), 1 sow and 4 piglets (farm A), 20 pigs (farm B), and from skin lesions of 3 piglets (farm A). Susceptibility testing showed that all MRSA isolates were susceptible to fusidic acid, trimethoprim/sulfamethoxazole, and enrofloxacin and resistant to ampicillin, tetracycline, gentamicin, and kanamycin. Of the 32 isolates, 18 were susceptible to lincomycin, tylosin, and erythromycin, and 14 were resistant to these antimicrobial drugs. Both resistance patterns were detected on both farms. The phenotypic resistance of the isolates to oxacillin was confirmed by Etest (AbBioDisk, Solna, Sweden) according to manufacturer’s guidelines. MICs were >128 mg/L for all MRSA isolates.
MRSA isolates were genotyped by using pulsed-field gel electrophoresis (PFGE) with SmaI according to the Harmony protocol (6), spa typing (7), and multilocus sequence typing (MLST) (8). Typing of the staphylococcal cassette chromosome (SCCmec) was performed by using PCR (9–11).
All isolates were nontypeable by PFGE with the SmaI restriction enzyme. Nontypeable MRSA associated with pig farming possesses DNA methylase, which methylates the SmaI-recognition sequence and leads to uninterpretable results (12). Genotyping showed that all isolates had spa type t011 and MLST 398 and SCCmec type IV (ccrA/B gene type 2, mec complex non–class A). Although 2 distinct resistance profiles were observed, all isolates belonged to the MLST/spa genotype associated with pigs in the Netherlands.
Because farm B regularly sells gilts to farm A, farm B is probably the source of the MRSA isolated from farm A. Farm B is a closed farm that has not purchased pigs since 1996. Further research is necessary to identify the source of MRSA on farm B.
Since 2002, human MRSA isolates sent to the National Institute for Public Health and the Environment by the regional laboratories are typed by PFGE, and nontypeable MRSA in persons who are not in contact with pigs is rare. The MRSA-positive farmer and student had no other known risk factors for MRSA carriage. The differences in the resistance patterns may be caused either by erythromycin-lincomycin-tylosin resistance genes located on mobile elements such as plasmids or transposons (like Tn554) or by differences in the expression of the resistance genes.
Transmission of MRSA between pigs and pig farmers has been previously reported by Voss et al. (3). However, to our knowledge, ours is the first report of culturing MRSA from clinically diseased pigs. The infected piglets were only 3 weeks of age, which suggests that they might have been infected through contact with their mother. The isolation of MRSA from piglets with exudative epidermitis was unexpected. That large numbers of S. aureus but no S. hyicus were cultured from the skin lesions indicates clinical relevance.
The sale of pigs to many different breeding farms favors the spread of MRSA. It was recently reported that 209 (39%) of 540 finishing pigs at Dutch slaughterhouses were MRSA positive and that all MRSA had MLST 398 and were resistant to tetracycline (13). Antimicrobial drugs, especially β-lactams and tetracyclines, may select for this MRSA strain. Farm A used many different antimicrobial drugs, including third-generation and fourth-generation cephalosporins, for treatment of exudative epidermitis; farm B regularly used amoxicillin. The diseased piglets were treated with enrofloxacin and recovered. Healthy pigs carrying MRSA should not be treated with antimicrobial drugs. Currently, no precautions are taken before and during slaughter of MRSA-positive pigs.
In conclusion, MRSA was cultured from clinically diseased and asymptomatic pigs. Colonization with MRSA seems to be widespread in Dutch pigs; supplier farms that sell MRSA-colonized pigs to other farms play a role in spreading the organism. Because the Netherlands exports pigs to other countries, further research on the prevalence of MRSA in pigs in foreign countries is warranted.
Dr van Duijkeren is assistant professor and veterinary microbiologist at the Faculty of Veterinary Medicine of Utrecht University. She studies the epidemiology of antimicrobial drug resistance in animals, with emphasis on Staphylococcus and Salmonella spp.
- Wertheim HF, Vos MC, Boelens HA, Voss A, Vandenbroucke-Grauls CM, Meester MH, Low prevalence of methicillin-resistant Staphylococcus aureus (MRSA) at hospital admission in the Netherlands: the value of search and destroy and restrictive antibiotic use. J Hosp Infect. 2004;56:321–5.
- Armand-Lefevre L, Ruimy R, Andremont A. Clonal comparison of Staphylococcus aureus isolates from healthy pig farmers, human controls, and pigs. Emerg Infect Dis. 2005;11:711–4.
- Voss A, Loeffen F, Bakker J, Klaassen C, Wulf M. Methicillin-resistant Staphylococcus aureus in pig farming. Emerg Infect Dis. 2005;11:1965–6.
- Commissie Richtlijnen Gevoeligheidsbepalingen. Interpretatie van gevoeligheidsonderzoek en gevoeligheidscriteria voor antibacteriële middelen in Nederland. Ned Tijdschr Med Microbiol. 2000;8:79–81.
- de Neeling AJ, van Leeuwen WJ, Schouls LM, Schot CS, van Veen-Rutgers A, Beunders AJ, Resistance of staphylococci in the Netherlands: surveillance by an electronic network during 1989–1995. J Antimicrob Chemother. 1998;41:93–101.
- Murchan S, Kaufmann ME, Deplano A, de Ryck R, Struelens M, Zinn CE, Harmonization of pulsed-field gel electrophoresis protocols for epidemiological typing of strains of methicillin-resistant Staphylococcus aureus: a single approach developed by consensus in 10 European laboratories and its application for tracing the spread of related strains. J Clin Microbiol. 2003;41:1574–85.
- Harmsen D, Claus H, Witte W, Rothganger J, Claus H, Turnwald D, Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol. 2003;41:5442–8.
- Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol. 2000;38:1008–15.
- Ito T, Katayama Y, Asada K, Mori N, Tsutsumimoto K, Tiensasitorn C, Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 2001;45:1323–36.
- Ito T, Ma XX, Takeuchi F, Okuma K, Yuzawa H, Hiramatsu K. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob Agents Chemother. 2004;48:2637–51.
- Okuma K, Iwakawa K, Turnidge JD, Grubb WB, Bell JM, O’Brien FG, Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol. 2002;40:4289–94.
- Bens CC, Voss A, Klaassen CH. Presence of a novel DNA methylation enzyme in methicillin-resistant Staphylococcus aureus isolates associated with pig farming leads to uninterpretable results in standard pulsed-field gel electrophoresis analysis. J Clin Microbiol. 2006;44:1875–6.
- Huijsdens XW, Spalburg EC. van Santen-Verheuvel, Dam-Deisz WDC, van den Broek MJM, de Neeling AJ. A survey of MRSA in pig farming. Proceedings of the 12th International Symposium on Staphylococci and Staphylococcal Infections. 2006 Sep 3–6; Maastricht, the Netherlands; 2006. p. 49–50.
Suggested citation for this article: van Duijkeren E, Jansen MD, Flemming SC, de Neeling H, Wagenaar JA, Schoormans AHW, et al. Methicillin-resistant Staphylococcus aureus in pigs with exudative epidermitis. Emerg Infect Dis [serial on the Internet]. 2007 Sep [date cited]. Available from http://wwwnc.cdc.gov/eid/article/13/9/06-1268
Please use the form below to submit correspondence to the authors or contact them at the following address:
Engeline van Duijkeren, Utrecht University, Yalelaan 1, Utrecht 3508 TD, the Netherlands;
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: July 01, 2010
- Page last updated: July 01, 2010
- Page last reviewed: July 01, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)